Literature DB >> 31445057

Sex differences in α-pyrrolidinopentiophenone (α-PVP)-induced taste avoidance, place preference, hyperthermia and locomotor activity in rats.

Katharine H Nelson1, Hayley N Manke2, Aikerim Imanalieva2, Kenner C Rice3, Anthony L Riley4.   

Abstract

RATIONALE: The majority of synthetic cathinone research has used only male subjects, and as a result there are few studies assessing the impact of biological sex on their effects.
OBJECTIVES: The current work extends the characterization of the second-generation synthetic cathinone, α-PVP, by investigating how biological sex impacts α-PVP's aversive and rewarding effects important to its use and potential abuse.
METHODS: A combined conditioned taste avoidance/conditioned place preference preparation was utilized in which adult male and female Sprague Dawley rats were injected with 1.5, 3 or 6 mg/kg of racemic α-PVP or vehicle (saline) (IP). Following a 24-day washout period, rats were then tested for thermoregulatory effects of α-PVP using subcutaneous microchips to measure body temperature changes over the course of 8 h. This was followed 21 days later by assessments for α-PVP-induced locomotor activity and stereotypies over a 1-h session.
RESULTS: Dose-dependent conditioned taste avoidance was evident in both males and females, although females displayed weaker avoidance at 3 mg/kg compared to males. Males displayed a dose-dependent conditioned place preference, while females did not form a place preference at any dose. α-PVP elicited dose- and time-dependent hyperthermia, with males displaying a faster on-set and delayed off-set compared to females. α-PVP also produced dose- and time-dependent increases in locomotor activity (F > M) and stereotypies (M > F).
CONCLUSIONS: As described, males displayed greater rewarding (as indexed by place preference conditioning) and aversive (as indexed by taste avoidance, hyperthermia and stereotypies) effects of α-PVP. Although comparisons between males and females in α-PVP self-administration have not been reported, these data suggest that males may be more likely to use the drug. The implications for sex differences in human use of α-PVP were discussed.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Conditioned place preference; Conditioned taste avoidance; Hyperthermia; Locomotor activity; Rats; Sex; α-PVP

Mesh:

Substances:

Year:  2019        PMID: 31445057      PMCID: PMC6748333          DOI: 10.1016/j.pbb.2019.172762

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  79 in total

Review 1.  Sex Differences in Animal Models: Focus on Addiction.

Authors:  Jill B Becker; George F Koob
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

2.  Opinion: Sex inclusion in basic research drives discovery.

Authors:  Sabra L Klein; Londa Schiebinger; Marcia L Stefanick; Larry Cahill; Jayne Danska; Geert J de Vries; Melina R Kibbe; Margaret M McCarthy; Jeffrey S Mogil; Teresa K Woodruff; Irving Zucker
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-20       Impact factor: 11.205

3.  Flavor and location aversions produced by ethanol.

Authors:  C L Cunningham
Journal:  Behav Neural Biol       Date:  1979-11

4.  Sex differences in the effects of ethanol pre-exposure during adolescence on ethanol-induced conditioned taste aversion in adult rats.

Authors:  Luke K Sherrill; Claire Berthold; Wendy A Koss; Janice M Juraska; Joshua M Gulley
Journal:  Behav Brain Res       Date:  2011-07-08       Impact factor: 3.332

5.  Sex differences in the conditioned rewarding effects of cocaine.

Authors:  Scott J Russo; Shirzad Jenab; Sosimo J Fabian; Eugene D Festa; Lynne M Kemen; Vanya Quinones-Jenab
Journal:  Brain Res       Date:  2003-04-25       Impact factor: 3.252

6.  Sex differences in the acquisition of intravenously self-administered cocaine and heroin in rats.

Authors:  W J Lynch; M E Carroll
Journal:  Psychopharmacology (Berl)       Date:  1999-05       Impact factor: 4.530

7.  Compartment syndrome after "bath salts" use: a case series.

Authors:  Michael Levine; Rachel Levitan; Aaron Skolnik
Journal:  Ann Emerg Med       Date:  2013-01-12       Impact factor: 5.721

8.  Methamphetamine-induced dopamine and serotonin reductions in neostriatum are not gender specific in rats with comparable hyperthermic responses.

Authors:  M Fukumura; G D Cappon; H W Broening; C V Vorhees
Journal:  Neurotoxicol Teratol       Date:  1998 Jul-Aug       Impact factor: 3.763

9.  The hyperthermia mediated by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) is sensitive to sex differences.

Authors:  Richard P Wyeth; Edward M Mills; Alison Ullman; M Alexander Kenaston; Johanna Burwell; Jon E Sprague
Journal:  Toxicol Appl Pharmacol       Date:  2008-12-14       Impact factor: 4.219

10.  Excited delirium.

Authors:  Asia Takeuchi; Terence L Ahern; Sean O Henderson
Journal:  West J Emerg Med       Date:  2011-02
View more
  4 in total

1.  Sex differences in inflammatory cytokine levels following synthetic cathinone self-administration in rats.

Authors:  Julie A Marusich; Elaine A Gay; Delisha A Stewart; Bruce E Blough
Journal:  Neurotoxicology       Date:  2021-11-04       Impact factor: 4.294

2.  Ethanol pre-exposure differentially impacts the rewarding and aversive effects of α-pyrrolidinopentiophenone (α-PVP): Implications for drug use and abuse.

Authors:  Katharine H Nelson; Hayley N Manke; Jacob M Bailey; Anna Vlachos; Karina J Maradiaga; Shihui Huang; Tania D Weiss; Kenner C Rice; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2021-10-08       Impact factor: 3.533

Review 3.  Impact of the Aversive Effects of Drugs on Their Use and Abuse.

Authors:  Anthony L Riley; Hayley N Manke; Shihui Huang
Journal:  Behav Neurol       Date:  2022-04-20       Impact factor: 3.112

4.  Rewarding Effect of Catha edulis (Khat) and the Sex Differences to the Responses in Swiss Albino Mice.

Authors:  Abebaye Aragaw Limenie; Tesfaye Tolessa; Eyasu Makonnen; Daniel Seifu
Journal:  Psychol Res Behav Manag       Date:  2020-03-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.